Purchase Order 36C25619P1122
Award Date 6/13/19
Potential Completion Date 9/30/22
Potential Value $148K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fairfield, NJ 07004, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $1.44 million firm fixed-price purchase order to Vela Diagnostics USA Inc. on September 20, 2021, for the lease of FDA-approved Vela Sentosa Next Generation Sequencing systems to support human immunodeficiency virus (HIV) genotyping and drug resistance monitoring for military members and their beneficiaries. The contract, which extends through September 29, 2026, will be performed at the contractor's facility in Fairfield, New Jersey. No set-aside...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. to provide COVID-19 VELA TESTING REAGENTS AND CONSUMABLES. The contract, with a potential value of $184,029.47, has a completion date of June 25, 2021 and was awarded on June 11, 2020. This award, which did not have a set-aside, was made in support of the Coronavirus COVID-19 national interest action. Vela Diagnostics USA Inc. is a for-profit organization...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the VELA DIAGNOSTICS VIROKEY SENTOSA requirement. The award, made on January 13, 2021, is a firm-fixed-price purchase order with a potential value of $436,564.36 and a completion date of December 31, 2021. The contract does not have a set-aside designation. Through this award, Vela Diagnostics...
- The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Vela Diagnostics USA Inc. for the delivery of SARS-CoV-2 test reagents. The contract, valued at $86,922.21, has an ultimate completion date of October 8, 2021. Vela Diagnostics USA Inc. is a for-profit organization that has previously provided equipment rental, reagents, consumables, and research and development to support COVID-19 testing, HIV genotyping, and next-generation sequencing systems for various...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to Vela Diagnostics USA Inc., a for-profit organization, for the provision of laboratory testing equipment. The contract has a total small business set-aside designation and a potential value of $149,000.00. It supports the national interest action code for the Coronavirus COVID-19 response. Through past prime federal contract awards,...
- The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Vela Diagnostics USA Inc. for $31,206.40 to procure Sentosa SQ HIV genotyping reagent kits and consumables. This sole source award is for the FDA-approved Next Generation Sequencing (NGS) HIV-1 drug resistance assay, which Vela Diagnostics is the sole manufacturer of. The place of performance is Fairfield, New Jersey. This award is not associated with a larger contract vehicle and does not have a...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Roche Diagnostics Corporation for HCV and HIV viral load testing services. The $104,452.66 contract was awarded on October 5, 2021 through the Critical Analyzers, Laboratory GSA Schedule contract, with a completion date of April 4, 2022. Roche Diagnostics, as a foreign-owned for-profit manufacturer, has provided laboratory instruments, reagents, and testing services to various federal...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm-fixed-price contract to Vela Diagnostics USA Inc. for the research and development of a probe-based reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19. The contract, which was not set aside, has a potential value of $224,780 and a completion date of October 31, 2020. Vela Diagnostics USA Inc. is a global provider of integrated molecular...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $2,126,578.98 contract is for the provision of HCV (hepatitis C virus) genotype reagents to support testing and screening programs for veteran populations. The contract has no set-aside designation and is part of a larger $1.15 million blanket purchase agreement (BPA) and a $1.1 million BPA...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a definitive firm fixed-price contract to Roche Diagnostics Corporation on November 1, 2019, for molecular HIV polymerase chain reaction (PCR) cost-per-test services and equipment lease. The contract, valued at approximately $2.51 million with an ultimate completion date of May 31, 2025, was awarded without a set-aside designation through open competition. The award stems from a pre-solicitation opportunity posted...